Fredun Pharmaceuticals Limited (BOM:539730)

Fredun Pharmaceuticals Revenue

Fredun Pharmaceuticals had revenue of 1.20B INR in the quarter ending June 30, 2025, with 52.08% growth. This brings the company's revenue in the last twelve months to 4.97B, up 36.28% year-over-year. In the fiscal year ending March 31, 2025, Fredun Pharmaceuticals had annual revenue of 4.56B with 31.05% growth.

• Revenue (ttm): 4.97B
• Revenue Growth: +36.28%
• P/S Ratio: 1.18
• Revenue / Employee: 19.43M
• Employees: 256
• Market Cap: 5.88B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	4.56B	1.08B	31.05%
Mar 31, 2024	3.48B	734.81M	26.75%
Mar 31, 2023	2.75B	502.16M	22.37%
Mar 31, 2022	2.24B	906.43M	67.74%
Mar 31, 2021	1.34B	211.22M	18.74%